Estrone, also known as E1 or oestrone, is an endogenous estrogen and a member of the steroid hormone family. It is primarily produced in the ovaries, adipose tissue, and, to a lesser extent, the adrenal glands. As a naturally occurring estrogen, estrone is part of the broader class of sex hormones and is involved in various physiological processes. Researchers have observed that estrone plays a role in the regulation of the menstrual cycle and the development of secondary sexual characteristics. It is also a precursor to estradiol, the most potent form of estrogen, and can be converted back and forth between these forms depending on the body's needs. Estrone's mechanism of action involves binding to estrogen receptors, particularly estrogen receptor alpha, which leads to the regulation of gene expression and subsequent biological effects such as cell proliferation and differentiation. This hormone is considered a weak estrogen compared to estradiol, and its physiological significance is often overshadowed by its more potent counterpart. Pharmacokinetically, estrone is subject to significant first-pass metabolism when administered orally, resulting in low bioavailability. It is interconvertible with estradiol, and estrone sulfate serves as a large circulating reservoir. The half-life of estrone varies depending on the route of administration, and it is metabolized primarily in the liver. Clinically, estrone is not commonly used in hormone replacement therapy due to its weaker estrogenic activity. However, it is of interest in research contexts, particularly in the study of menopausal transitions and breast cancer. Regulatory standing varies by region, with estrone being available by prescription in some countries for specific indications.